The Mechanism of MicroRNAs Network in Alzheimer's Disease (MicroRNAs AD)

Shanghai Mental Health Center

Status: Completed

Conditions: Alzheimer Disease

Treatments: Diagnostic Test: MicRNAs test

Study type: Observational

Funder types: Other

Identifiers

NCT05055310

81571298

Details and patient eligibility

About

MicroRNAs network, such as MicRNA107 et al, regulate the pathology of Alzheimer's disease and the clinical validation in diagnosis AD.

Enrollment: 1,000 patients

Sex: All

Ages: 60 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• NIA-AA MCI due to AD clinical criteria for MCI due to AD
• NIA-AA AD clinical criteria for AD

Exclusion criteria

• Other type of dementia

Trial design

1,000 participants in 3 patient groups

Normal elderly

Description:

normal cognitive group

Treatment:

Diagnostic Test: MicRNAs test

aMCI

Description:

amnestic mild cognitive impairment

Treatment:

Diagnostic Test: MicRNAs test

AD

Description:

Alzhiemer's disease

Treatment:

Diagnostic Test: MicRNAs test